COLUMBUS, Ohio--(BUSINESS WIRE)--Deep Lens announced today that Kamala Maddali, DVM, PhD, has been appointed to the Society for Clinical Research Sites (SCRS) Oncology Program Board. Dr. Maddali’s appointment to the SCRS Oncology Board was effective August 12, 2020.
"We are pleased to have Dr. Maddali join our board and look forward to benefiting from her extensive biotech, pharma, clinical trials, diagnostics, and life sciences experience in precision medicine," said Jimmy Bechtel, MBA, director of innovation and engagement of SCRS. "In light of our focus in oncology, we believe having a board member with significant leadership experience in precision medicine and a patient advocate will provide our board with a valuable perspective."
Dr. Maddali currently serves as Vice President of Strategic Alliances for Deep Lens. Prior to Deep Lens, Dr. Maddali served as a chief scientific and commercial executive for many notable Fortune 500 companies, including Merck and Co., Quintiles, and Quest Diagnostics, where she led strategic initiatives to foster positive growth in precision medicine. She also served as an executive advisor for several healthcare technology companies, focused on artificial intelligence, blockchain genomics, nutraceuticals, and bioinformatics, and biotechnology companies, focused on unique precision medicine driven solutions.
The SCRS board is comprised of CROs, sponsors, and sites and meets regularly to create greater efficiency and sustainability for sites working with oncology patients through education, research, and other resources. Dr. Maddali will serve as a member on three individual workstreams: SCRS Global Oncology Site Solutions Summit, SCRS Oncology Education Resources, and SCRS Oncology Assessment/Engagement.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. For more info, visit MySCRS.org.
About Deep Lens
Deep Lens is a software company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials. By identifying patients at the time of diagnosis and combining lab, EMR. and genomic data, VIPER, Deep Lens’ integrated cloud platform, provides care teams with visibility and workflows to accelerate recruitment and compress study timelines to bring game-changing therapies to market sooner. Growing with sponsors, providers and strategic partners, Deep Lens challenges the status quo so that patients can get the therapies they want and deserve. For more info, visit deeplens.ai.